MA28903B1 - Derives de metastine et leur utilisation - Google Patents

Derives de metastine et leur utilisation

Info

Publication number: MA28903B1
Authority: MA; Morocco
Prior art keywords: metastin derivatives; metastin; derivatives
Prior art date: 2004-06-25

Application number

MA29567A

Other languages

English (en)

Inventor

Chieko Kitada

Taiji Asami

Naoki Nishizawa

Original Assignee

Takeda Pharmaceutical

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-06-25

Filing date

2006-12-28

Publication date

2007-10-01

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34971534&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA28903(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2006-12-28 Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical

2007-10-01 Publication of MA28903B1 publication Critical patent/MA28903B1/fr

Links

KAHDONZOCXSKII-NJVVDGNHSA-N kisspeptin Chemical class C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H]1N(CCC1)C(=O)[C@H]1N(CCC1)C(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)O)C1=CN=CN1 KAHDONZOCXSKII-NJVVDGNHSA-N 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4703—Inhibitors; Suppressors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Hematology (AREA)
Reproductive Health (AREA)
Obesity (AREA)
Urology & Nephrology (AREA)
Neurology (AREA)
Immunology (AREA)
Gynecology & Obstetrics (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Emergency Medicine (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Toxicology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Pregnancy & Childbirth (AREA)
Pulmonology (AREA)
Cardiology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)

MA29567A 2004-06-25 2006-12-28 Derives de metastine et leur utilisation MA28903B1 (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP2004187671		2004-06-25
JP2004363311		2004-12-15

Publications (1)

Publication Number	Publication Date
MA28903B1 true MA28903B1 (fr)	2007-10-01

Family

ID=34971534

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA29567A MA28903B1 (fr)	2004-06-25	2006-12-28	Derives de metastine et leur utilisation

Country Status (20)

Country	Link
US (2)	US7625869B2 (fr)
EP (2)	EP1758932A2 (fr)
JP (3)	JP4346650B2 (fr)
CN (2)	CN101845091A (fr)
AR (1)	AR049938A1 (fr)
AU (1)	AU2005257484A1 (fr)
BR (1)	BRPI0512397A (fr)
CA (1)	CA2571420A1 (fr)
CL (1)	CL2008003730A1 (fr)
CR (1)	CR8828A (fr)
IL (1)	IL179640A0 (fr)
MA (1)	MA28903B1 (fr)
MX (1)	MXPA06014206A (fr)
NO (1)	NO20065957L (fr)
NZ (1)	NZ552029A (fr)
PE (2)	PE20091567A1 (fr)
RU (1)	RU2006145886A (fr)
SG (1)	SG153865A1 (fr)
TW (1)	TW200607816A (fr)
WO (1)	WO2006001499A2 (fr)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2425392T3 (es)	2002-03-20	2013-10-15	Mannkind Corporation	Cartucho para un aparato de inhalación
EP1577323B1 (fr)	2002-12-26	2013-07-10	Takeda Pharmaceutical Company Limited	Derive de la metastine et son utilisation
CA2518541C (fr)	2003-03-12	2013-05-21	Takeda Pharmaceutical Company Limited	Agents ameliorant la fonction gonadique
CA2560513A1 (fr)	2004-04-08	2005-12-01	Biomatrica, Inc.	Integration du stockage et de la gestion d'echantillons pour les sciences de la vie
NZ552029A (en)	2004-06-25	2009-01-31	Takeda Pharmaceutical	Metastin derivatives and use thereof
ES2385934T3 (es)	2004-08-20	2012-08-03	Mannkind Corporation	Catálisis de la síntesis de dicetopiperazina.
HUE025151T2 (en)	2004-08-23	2016-01-28	Mannkind Corp	Diceto-piperazine salts for drug delivery
US7799344B2 (en)	2005-09-14	2010-09-21	Mannkind Corporation	Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
AR058584A1 (es) *	2005-12-22	2008-02-13	Takeda Pharmaceutical	Derivados de metastina y uso de los mismos
US8404643B2 (en) *	2005-12-22	2013-03-26	Takeda Pharmaceutical Company Limited	Metastin derivatives and use thereof
US20090093615A1 (en) *	2005-12-22	2009-04-09	Takeda Pharmaceutical Company Limited	Metastin derivatives and use thereof
US8039431B2 (en)	2006-02-22	2011-10-18	Mannkind Corporation	Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
JP5279021B2 (ja) *	2006-04-26	2013-09-04	国立大学法人京都大学	Ｇｐｒ５４アゴニスト活性を有する新規化合物
ITMI20061607A1 (it)	2006-08-09	2008-02-10	Maria Vincenza Carriero	Peptidi con attivita farmacologica
JO3048B1 (ar) *	2006-10-25	2016-09-05	Takeda Pharmaceuticals Co	مشتقات متاستين واستخدامها
UA94774C2 (en) *	2006-10-25	2011-06-10	Такеда Фармасьютикал Компани Лимитед	Metastin derivatives and use thereof
JPWO2009131191A1 (ja) *	2008-04-24	2011-08-25	武田薬品工業株式会社	メタスチン誘導体およびその用途
WO2009139298A1 (fr) *	2008-04-30	2009-11-19	国立大学法人京都大学	Dérivé de metastine et son utilisation
DK2293833T3 (en)	2008-06-13	2016-05-23	Mannkind Corp	DRY POWDER INHALER AND MEDICINAL ADMINISTRATION SYSTEM
US8485180B2 (en)	2008-06-13	2013-07-16	Mannkind Corporation	Dry powder drug delivery system
JP5479465B2 (ja)	2008-06-20	2014-04-23	マンカインドコーポレイション	吸入努力をリアルタイムにプロファイルする対話式機器および方法
US20110212890A1 (en) *	2008-07-30	2011-09-01	Takeda Pharmaceutical Company Limited	Metastin derivative and use thereof
AU2009334235A1 (en) *	2008-12-29	2010-07-08	Takeda Pharmaceutical Company Limited	Prophylactic/therapeutic agent for cancer
US8314106B2 (en)	2008-12-29	2012-11-20	Mannkind Corporation	Substituted diketopiperazine analogs for use as drug delivery agents
US8716228B2 (en)	2009-05-27	2014-05-06	Yeda Research And Development Co. Ltd.	GPR54 agonists or antagonists for treatment of diseases presenting behavioral abnormalities
ES2434315T3 (es)	2009-12-22	2013-12-16	Takeda Pharmaceutical Company Limited	Formulación de liberación sostenida
IL223742A (en)	2010-06-21	2016-06-30	Mannkind Corp	A dry powder inhaler and preparation for it
US9376709B2 (en)	2010-07-26	2016-06-28	Biomatrica, Inc.	Compositions for stabilizing DNA and RNA in blood and other biological samples during shipping and storage at ambient temperatures
WO2012018639A2 (fr)	2010-07-26	2012-02-09	Biomatrica, Inc.	Compositions de stabilisation d'adn, d'arn, de protéines salivaires et d'autres échantillons biologiques lors du transport et du stockage à températures ambiantes
MY180552A (en)	2011-04-01	2020-12-02	Mannkind Corp	Blister package for pharmaceutical cartridges
WO2012174472A1 (fr)	2011-06-17	2012-12-20	Mannkind Corporation	Microparticules de dicétopipérazine de capacité élevée
EP2755690B1 (fr)	2011-08-04	2020-04-01	Merck Sharp & Dohme B.V.	Conjugués du kisspeptide avec un pentasaccharide
EP2776053A1 (fr)	2011-10-24	2014-09-17	MannKind Corporation	Procédés et compositions pour traiter la douleur
US9382293B2 (en)	2012-03-14	2016-07-05	Yeda Research And Development Co. Ltd.	Modified kisspeptin peptides and uses thereof
SG11201500218VA (en)	2012-07-12	2015-03-30	Mannkind Corp	Dry powder drug delivery systems and methods
EP2934572A4 (fr)	2012-12-20	2016-11-23	Biomatrica Inc	Formulations et procédés pour stabiliser des réactifs pcr
JP6143270B2 (ja) *	2013-01-31	2017-06-07	学校法人東京薬科大学	マイオスタチン阻害ペプチド
MX394255B (es)	2013-07-18	2025-03-24	Mannkind Corp	Composiciones farmaceuticas en polvo seco estables al calor y metodos
US10220069B2 (en) *	2014-01-22	2019-03-05	The Johns Hopkins University	Compositions and methods for treating diabetes
US10307464B2 (en)	2014-03-28	2019-06-04	Mannkind Corporation	Use of ultrarapid acting insulin
ES2786373T3 (es)	2014-06-10	2020-10-09	Biomatrica Inc	Estabilización de trombocitos a temperaturas ambiente
CN113588501B (zh)	2015-12-08	2024-12-17	生物马特里卡公司	降低红细胞沉降速率
IL265696B2 (en)	2016-09-30	2024-08-01	Sumitomo Pharma Switzerland Gmbh	2-(n-acetyl-d-tyrosyl-trans-4-hydroxy-l-prolyl-l-asparaginyl-l-threonyl-l-phenylalanyl) hydrazinocarbonyl-l-leucyl-nω-methyl-l-arginyl-l-tryptophanamide, for use in assisted reproductive technology.
CN109206481B (zh)	2017-07-05	2023-08-18	尚华医药科技(江西)有限公司	一种肽类化合物、其应用及含其的组合物
CN108752233B (zh) *	2018-07-18	2020-10-16	河北师范大学	小分子凝胶因子、凝胶材料及制备方法和应用
CA3174239A1 (fr) *	2020-05-08	2021-11-11	Yousef Al-Abed	Dimeres destines a etre utilises dans la synthese de peptidomimetiques
WO2025217074A1 (fr)	2024-04-08	2025-10-16	Radionetics Oncology, Inc.	Agents thérapeutiques ciblant le récepteur de la kisspeptine (kiss1r) et leurs utilisations

Family Cites Families (54)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1524747A (en) *	1976-05-11	1978-09-13	Ici Ltd	Polypeptide
FR2488253A1 (fr) *	1980-08-08	1982-02-12	Roques Bernard	Nouveaux peptides et leur application en therapeutique
IL74827A (en) *	1984-05-21	1989-06-30	Salk Inst For Biological Studi	Peptides active as gnrh antagonists and pharmaceutical compositions containing them
MX9100717A (es) *	1990-08-24	1992-04-01	Syntex Inc	Antagonistas de la bradiquinina
US5824784A (en)	1994-10-12	1998-10-20	Amgen Inc.	N-terminally chemically modified protein compositions and methods
JPH09169735A (ja)	1995-10-19	1997-06-30	Takeda Chem Ind Ltd	キノリン誘導体、その製造法および用途
CA2229201A1 (fr)	1995-10-19	1997-04-24	Satoshi Sasaki	Derives de la quinoleine en tant qu'antagonistes du gn-rh
WO1997040071A1 (fr)	1996-04-19	1997-10-30	Novo Nordisk A/S	Composes capables de liberer une hormone de croissance
CA2283299A1 (fr)	1997-03-07	1998-09-11	Human Genome Sciences, Inc.	186 nouvelles proteines secretees
JP4486187B2 (ja)	1998-10-27	2010-06-23	武田薬品工業株式会社	新規ｇ蛋白質共役型レセプター蛋白質、そのｄｎａおよびそのリガンド
US6528054B1 (en)	1998-12-28	2003-03-04	Corixa Corporation	Compositions and methods for the therapy and diagnosis of breast cancer
AU5406000A (en)	1999-06-28	2001-01-31	Basf Aktiengesellschaft	Method for preventing tumoral growth
US6638906B1 (en)	1999-12-13	2003-10-28	Nobex Corporation	Amphiphilic polymers and polypeptide conjugates comprising same
JP2001231581A (ja) *	1999-12-17	2001-08-28	Takeda Chem Ind Ltd	ＫｉＳＳ−１ペプチドの製造法
WO2001044469A1 (fr)	1999-12-17	2001-06-21	Takeda Chemical Industries, Ltd.	PROCEDE DE PRODUCTION DE PEPTIDE KiSS-1
CZ20023567A3 (cs)	2000-03-29	2003-11-12	Corixa Corporation	Sloučeniny a způsoby pro terapii a diagnostiku karcinomu plic
WO2001075104A1 (fr)	2000-03-30	2001-10-11	Takeda Chemical Industries, Ltd.	Nouvelle proteine, adn codant pour celle-ci, et son procede de production
US7834141B1 (en)	2000-03-31	2010-11-16	Theresa Siler-Khodr	Non-mammalian GnRH analogs and uses thereof in tumor cell growth regulation and cancer therapy
RU2311920C2 (ru)	2000-09-20	2007-12-10	Корикса Корпорейшн	Композиции и способы для лечения и диагностики рака легких
JP2003026601A (ja)	2000-11-29	2003-01-29	Takeda Chem Ind Ltd	医薬組成物およびその製造法
JP2002320496A (ja)	2001-02-26	2002-11-05	Takeda Chem Ind Ltd	新規マウス型ＫｉＳＳ−１レセプタータンパク質およびそのＤＮＡ
WO2002085399A1 (fr)	2001-04-20	2002-10-31	Takeda Chemical Industries, Ltd.	Preparations contenant un peptide
EP1391518A4 (fr) *	2001-05-17	2006-06-28	Shimadzu Corp	Procede de production d'un peptide
DE60219645T2 (de)	2001-09-19	2007-08-09	Takeda Pharmaceutical Co. Ltd.	Antikörper gegen metastin und dessen verwendung zur diagnose von schwangerschaft
US20050176091A1 (en) *	2002-01-11	2005-08-11	Takao Yamada	Process for producing kiss-1 peptide
JP2003300906A (ja)	2002-04-12	2003-10-21	Daiichi Fine Chemical Co Ltd	がん転移抑制因子の安定化
EP1568381A1 (fr) *	2002-10-09	2005-08-31	Kyowa Hakko Kogyo Co., Ltd.	Remede destine a un cancer hormone-dependant
WO2004038021A1 (fr)	2002-10-25	2004-05-06	Paradigm Therapeutics Limited	Mammiferes « inactives » gpr54 et procedes de criblage utilisant ces mammiferes
JP4804714B2 (ja)	2002-12-26	2011-11-02	武田薬品工業株式会社	メタスチン誘導体およびその用途
EP1577323B1 (fr) *	2002-12-26	2013-07-10	Takeda Pharmaceutical Company Limited	Derive de la metastine et son utilisation
US6800611B2 (en)	2003-01-06	2004-10-05	Takeda Chemical Industries, Ltd.	Metastin derivatives and their use
KR100595364B1 (ko)	2003-02-20	2006-07-03	재단법인 목암생명공학연구소	Ｌｋ8 단백질을 유효성분으로 포함하는 항암제
CA2518541C (fr) *	2003-03-12	2013-05-21	Takeda Pharmaceutical Company Limited	Agents ameliorant la fonction gonadique
EP1464652A1 (fr)	2003-04-02	2004-10-06	Institut National De La Sante Et De La Recherche Medicale (Inserm)	Agoniste et antagoniste du récepteur GPR54 utiles pour le traitement des maladies associées à la gonadotrophine
US20050002935A1 (en)	2003-04-17	2005-01-06	Vincent Ling	Use of B7-H3 as an immunoregulatory agent
EP1618384A2 (fr)	2003-04-28	2006-01-25	Wyeth	Procedes et compositions permettant de moduler le recepteur 54 couple a une proteine g
WO2004101747A2 (fr)	2003-05-07	2004-11-25	The General Hospital Corporation	Identification et utilisation de gpr54 et de ses ligands pour les troubles de la reproduction et la contraception
ES2308181T3 (es)	2003-05-30	2008-12-01	Prozymex A/S	Inhibidores de proteasa.
JP4688678B2 (ja)	2003-11-03	2011-05-25	北京沙東生物技術有限公司	抗癌作用を有する組換えタンパク質、それをコードする遺伝子、及びそれらの使用
RU2333221C2 (ru)	2003-11-03	2008-09-10	Бейцзин Санбио Байотек Ко., Лтд.	Рекомбинантный белок, обладающий противораковым действием, кодирующий его ген и его применение
WO2005095973A2 (fr)	2004-03-25	2005-10-13	Bayer Healthcare Ag	Methodes diagnostiques et therapeutiques pour des maladies associees au recepteur 54 couple a la proteine g (gpr54)
WO2005117939A2 (fr)	2004-04-23	2005-12-15	Applied Research Systems Ars Holding N.V.	Utilisation de ligands gpcr54 pour le traitement de l'infertilite
NZ552029A (en) *	2004-06-25	2009-01-31	Takeda Pharmaceutical	Metastin derivatives and use thereof
WO2007084211A2 (fr)	2005-11-11	2007-07-26	The General Hospital Corporation	Utilisation de ligands du gpr54 pour le traitement de troubles de la reproduction, de troubles proliferatifs et pour la contraception
US8404643B2 (en) *	2005-12-22	2013-03-26	Takeda Pharmaceutical Company Limited	Metastin derivatives and use thereof
US20090099334A1 (en) *	2005-12-22	2009-04-16	Takeda Pharmaceutical Company Limited	Metastin derivatives and use thereof
AR058584A1 (es) *	2005-12-22	2008-02-13	Takeda Pharmaceutical	Derivados de metastina y uso de los mismos
US20090093615A1 (en) *	2005-12-22	2009-04-09	Takeda Pharmaceutical Company Limited	Metastin derivatives and use thereof
BRPI0708943A2 (pt)	2006-03-20	2011-06-14	Merck & Co Inc	agonista do receptor de neuromidina u, mÉtodos para produÇço de um agonista do receptor de neuromidina u e para o tratamento de um distérbio metabàlico em um indivÍduo, uso do agonista do receptor de neuromedina u, e, composiÇço farmacÊutica
JP2009536611A (ja) *	2006-03-28	2009-10-15	バイオファルミカリミテッド	ホルモン依存性障害の処置のための作用物質及びその使用
JO3048B1 (ar) *	2006-10-25	2016-09-05	Takeda Pharmaceuticals Co	مشتقات متاستين واستخدامها
US20100286035A1 (en) *	2007-10-05	2010-11-11	Takeda Pharmaceutical Company Limited	Neuromedin u derivative
JPWO2009131191A1 (ja) *	2008-04-24	2011-08-25	武田薬品工業株式会社	メタスチン誘導体およびその用途
US20110171160A1 (en)	2008-09-19	2011-07-14	Nektar Therapeutics	Polymer conjugates of kiss1 peptides

2005
- 2005-06-23 NZ NZ552029A patent/NZ552029A/en not_active IP Right Cessation
- 2005-06-23 WO PCT/JP2005/012021 patent/WO2006001499A2/fr not_active Ceased
- 2005-06-23 EP EP05755666A patent/EP1758932A2/fr not_active Withdrawn
- 2005-06-23 JP JP2006554374A patent/JP4346650B2/ja not_active Expired - Fee Related
- 2005-06-23 CA CA002571420A patent/CA2571420A1/fr not_active Abandoned
- 2005-06-23 PE PE2009000637A patent/PE20091567A1/es not_active Application Discontinuation
- 2005-06-23 PE PE2005000728A patent/PE20060371A1/es not_active Application Discontinuation
- 2005-06-23 CN CN200910225195A patent/CN101845091A/zh active Pending
- 2005-06-23 AU AU2005257484A patent/AU2005257484A1/en not_active Abandoned
- 2005-06-23 RU RU2006145886/04A patent/RU2006145886A/ru not_active Application Discontinuation
- 2005-06-23 TW TW094120917A patent/TW200607816A/zh unknown
- 2005-06-23 SG SG200904360-5A patent/SG153865A1/en unknown
- 2005-06-23 MX MXPA06014206A patent/MXPA06014206A/es unknown
- 2005-06-23 EP EP09075257.7A patent/EP2113513B1/fr not_active Expired - Lifetime
- 2005-06-23 US US11/630,698 patent/US7625869B2/en not_active Expired - Fee Related
- 2005-06-23 AR ARP050102591A patent/AR049938A1/es unknown
- 2005-06-23 CN CN200910225194A patent/CN101863971A/zh active Pending
- 2005-06-23 BR BRPI0512397-6A patent/BRPI0512397A/pt not_active IP Right Cessation
2006
- 2006-11-27 IL IL179640A patent/IL179640A0/en unknown
- 2006-12-21 NO NO20065957A patent/NO20065957L/no not_active Application Discontinuation
- 2006-12-22 CR CR8828A patent/CR8828A/es not_active Application Discontinuation
- 2006-12-28 MA MA29567A patent/MA28903B1/fr unknown
2008
- 2008-09-25 JP JP2008245073A patent/JP4654284B2/ja not_active Expired - Fee Related
- 2008-10-01 US US12/286,671 patent/US8778871B2/en active Active
- 2008-12-15 CL CL2008003730A patent/CL2008003730A1/es unknown
2009
- 2009-06-01 JP JP2009132363A patent/JP2009227687A/ja active Pending

Also Published As

Publication number	Publication date
BRPI0512397A (pt)	2008-03-04
AU2005257484A1 (en)	2006-01-05
SG153865A1 (en)	2009-07-29
MXPA06014206A (es)	2007-02-14
JP2009227687A (ja)	2009-10-08
CA2571420A1 (fr)	2006-01-05
US20090298765A1 (en)	2009-12-03
US7625869B2 (en)	2009-12-01
EP2113513A3 (fr)	2010-11-03
JP4346650B2 (ja)	2009-10-21
JP4654284B2 (ja)	2011-03-16
IL179640A0 (en)	2007-05-15
CN101845091A (zh)	2010-09-29
CR8828A (es)	2007-07-19
JP2008506632A (ja)	2008-03-06
EP2113513B1 (fr)	2016-05-18
US20080312155A1 (en)	2008-12-18
NZ552029A (en)	2009-01-31
RU2006145886A (ru)	2008-06-27
CN101863971A (zh)	2010-10-20
PE20060371A1 (es)	2006-06-15
PE20091567A1 (es)	2009-11-03
TW200607816A (en)	2006-03-01
WO2006001499A3 (fr)	2006-03-02
NO20065957L (no)	2007-01-25
US8778871B2 (en)	2014-07-15
WO2006001499A2 (fr)	2006-01-05
JP2009024028A (ja)	2009-02-05
EP1758932A2 (fr)	2007-03-07
CL2008003730A1 (es)	2009-05-04
AR049938A1 (es)	2006-09-13
EP2113513A2 (fr)	2009-11-04

Publication	Publication Date	Title
MA28903B1 (fr)	2007-10-01	Derives de metastine et leur utilisation
EP1731506A4 (fr)	2009-12-09	Derives de 5-hydroxyindol-3-carboxylate et leur utilisation
EP1826209A4 (fr)	2010-05-19	Derives de nitromethylene et leur utilisation
EP1971600A4 (fr)	2011-06-15	Derives d'isoxasole et leur utilisation
EP1954140A4 (fr)	2009-12-23	Cetals de glycerol-levulinate et utilisation
MA29039B1 (fr)	2007-11-01	Dibenzylamines et derives
FI20070841L (fi)	2007-11-07	Kondensaattorinvaraamismenetelmiä ja -laitteistoja
CR10743A (es)	2009-06-05	Derivados de azaadamantano y metodos de uso de los mismos
ATA7452004A (de)	2005-04-15	Trocknungsvorrichtung
DK2081955T3 (da)	2015-06-15	Metastinderivater og anvendelse deraf
DK1809978T3 (da)	2014-01-20	Modul-skydebane
IL190888A0 (en)	2008-11-03	Metastin derivatives and use thereof
BRPI0812909A2 (pt)	2014-12-09	Derivados de guanina policíclica e métodos de uso dos mesmos.
DE602004025215D1 (de)	2010-03-11	Tastsonde
FI20040351L (fi)	2005-09-05	Mittausmenetelmä ja -järjestely
EP1718662A4 (fr)	2008-12-31	Sondes de detection multiplex
ATE500227T1 (de)	2011-03-15	Amidderivate
EP2213675A4 (fr)	2011-10-26	Dérivé de pyridooxazépine et son utilisation
MA28859B1 (fr)	2007-09-03	Hexadecasaccharides biotinyles, leur preparation et leur utilisation
DK1885716T3 (da)	2013-02-11	Thiazolderivater og anvendelse deraf
EP1961753A4 (fr)	2009-11-25	Derives de la pirazolopyrimidinone, leur preparation et leur utilisation
DE502005000300D1 (de)	2007-02-22	Tastkopf
DE602004031602D1 (de)	2011-04-14	Vorverstärker
DK1789800T3 (da)	2009-09-07	Ileitis-diagnosetest
ATE365731T1 (de)	2007-07-15	4-amino-5-cyanopyrimidinderivate